Business Segments (Tables)

6 Months Ended

Sep. 30, 2026

Schedule of Operating and Reportable Segments

The tables below summarize information about our reportable segments.


	Three Months Ended September 30, 2026
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Total segment revenues*	$	271,812	$	64,495	$	336,307
Cost of sales	132,992		30,777		163,769
Gross profit	138,820		33,718		172,538
Advertising and marketing	40,488		11,738		52,226
Contribution margin	$	98,332	$	21,980	$	120,312
Other operating expenses					39,600
Operating income					$	80,712
* Intersegment revenues of $0.9 million were eliminated from the North American OTC Healthcare segment.


	Six Months Ended September 30, 2026
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Total segment revenues*	$	498,018	$	103,999	$	602,017
Cost of sales	243,257		50,034		293,291
Gross profit	254,761		53,965		308,726
Advertising and marketing	69,418		17,476		86,894
Contribution margin	$	185,343	$	36,489	$	221,832
Other operating expenses					88,600
Operating income					$	133,232
* Intersegment revenues of $1.6 million were eliminated from the North American OTC Healthcare segment.


	Three Months Ended September 30, 2025
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Total segment revenues*	$	230,756	$	43,358	$	274,114
Cost of sales	102,348		20,187		122,535
Gross profit	128,408		23,171		151,579
Advertising and marketing	32,033		6,668		38,701
Contribution margin	$	96,375	$	16,503	$	112,878
Other operating expenses					33,208
Operating income					$	79,670
* Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment.


	Six Months Ended September 30, 2025
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Total segment revenues*	$	443,334	$	80,310	$	523,644
Cost of sales	194,526		37,208		231,734
Gross profit	248,808		43,102		291,910
Advertising and marketing	60,987		12,651		73,638
Contribution margin	$	187,821	$	30,451	$	218,272
Other operating expenses					66,846
Operating income					$	151,426
* Intersegment revenues of $1.2 million were eliminated from the North American OTC Healthcare segment.

Schedule of Revenues from Similar Product Groups

The tables below summarize information about our segment revenues from similar product groups.


	Three Months Ended September 30, 2026
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Cough, Cold & Allergy	$	27,221	$	9,101	$	36,322
Dermatologicals	34,274		9,584		43,858
Eye & Ear Care	29,165		5,448		34,613
Gastrointestinal	43,958		19,156		63,114
Oral Care	22,869		3,731		26,600
Pain Relief	29,223		1,667		30,890
Wellness, Sleep & Other	37,201		10,120		47,321
Women's Health	47,901		5,688		53,589
Total segment revenues	$	271,812	$	64,495	$	336,307


	Six Months Ended September 30, 2026
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Cough, Cold & Allergy	$	42,849	$	14,778	$	57,627
Dermatologicals	64,889		12,164		77,053
Eye & Ear Care	57,504		10,087		67,591
Gastrointestinal	91,099		34,217		125,316
Oral Care	41,327		7,631		48,958
Pain Relief	55,448		2,244		57,692
Wellness, Sleep & Other	49,760		11,888		61,648
Women's Health	95,142		10,990		106,132

Total segment revenues	$	498,018	$	103,999	$	602,017


	Three Months Ended September 30, 2025
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Cough, Cold & Allergy	$	20,472	$	6,813	$	27,285
Dermatologicals	32,792		2,904		35,696
Eye & Ear Care	29,387		4,790		34,177
Gastrointestinal	46,413		17,787		64,200
Oral Care	21,039		3,728		24,767
Pain Relief	27,232		1,501		28,733
Wellness, Sleep & Other	6,127		277		6,404
Women's Health	47,294		5,558		52,852

Total segment revenues	$	230,756	$	43,358	$	274,114


	Six Months Ended September 30, 2025
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Cough, Cold & Allergy	$	33,825	$	12,467	$	46,292
Dermatologicals	60,644		5,161		65,805
Eye & Ear Care	57,168		9,317		66,485
Gastrointestinal	90,109		31,875		121,984
Oral Care	39,193		7,276		46,469
Pain Relief	54,490		3,175		57,665
Wellness, Sleep & Other	10,853		659		11,512
Women's Health	97,052		10,380		107,432


Total segment revenues	$	443,334	$	80,310	$	523,644

- Definition

Tabular disclosure of segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26A

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

+ Details